

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular extravasation (GO:0045123) | 6.48245511 |
| 2 | response to peptidoglycan (GO:0032494) | 5.70584856 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.76242651 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.76242651 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 4.76242651 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.76242651 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.76242651 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.76242651 |
| 9 | negative regulation of interleukin-12 production (GO:0032695) | 4.75622365 |
| 10 | neutrophil mediated immunity (GO:0002446) | 4.70063931 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 4.58919748 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.48468302 |
| 13 | microglial cell activation (GO:0001774) | 4.41110874 |
| 14 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.28114338 |
| 15 | neutrophil activation (GO:0042119) | 4.26875928 |
| 16 | detection of molecule of bacterial origin (GO:0032490) | 4.25597067 |
| 17 | leukocyte aggregation (GO:0070486) | 4.13990168 |
| 18 | macrophage activation involved in immune response (GO:0002281) | 4.12357954 |
| 19 | detection of other organism (GO:0098543) | 4.07554841 |
| 20 | negative regulation of interleukin-1 production (GO:0032692) | 4.07493808 |
| 21 | negative regulation of cell killing (GO:0031342) | 4.06472542 |
| 22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.06472542 |
| 23 | negative regulation of interleukin-1 beta production (GO:0032691) | 4.05811637 |
| 24 | respiratory burst (GO:0045730) | 3.96741457 |
| 25 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.94213984 |
| 26 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.94190757 |
| 27 | response to host immune response (GO:0052572) | 3.94190757 |
| 28 | granulocyte activation (GO:0036230) | 3.92777088 |
| 29 | positive regulation of mast cell activation (GO:0033005) | 3.86885042 |
| 30 | regulation of mast cell activation (GO:0033003) | 3.84827609 |
| 31 | macrophage activation (GO:0042116) | 3.84259114 |
| 32 | myeloid leukocyte mediated immunity (GO:0002444) | 3.80996917 |
| 33 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.77287488 |
| 34 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.71436426 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.65925280 |
| 36 | defense response to fungus (GO:0050832) | 3.65575067 |
| 37 | detection of external biotic stimulus (GO:0098581) | 3.63868968 |
| 38 | detection of biotic stimulus (GO:0009595) | 3.60332541 |
| 39 | detection of bacterium (GO:0016045) | 3.58244876 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 3.55402199 |
| 41 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.55115939 |
| 42 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.48882962 |
| 43 | neutrophil chemotaxis (GO:0030593) | 3.42115744 |
| 44 | response to host defenses (GO:0052200) | 3.40662931 |
| 45 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.40662931 |
| 46 | response to host (GO:0075136) | 3.40662931 |
| 47 | negative regulation of interleukin-6 production (GO:0032715) | 3.39620585 |
| 48 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.38713125 |
| 49 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.35555536 |
| 50 | positive regulation of mast cell degranulation (GO:0043306) | 3.35555536 |
| 51 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.34679760 |
| 52 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.34679760 |
| 53 | neutrophil migration (GO:1990266) | 3.33763601 |
| 54 | myeloid cell activation involved in immune response (GO:0002275) | 3.31545731 |
| 55 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.30340244 |
| 56 | response to fungus (GO:0009620) | 3.28776220 |
| 57 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.27234521 |
| 58 | regulation of growth of symbiont in host (GO:0044126) | 3.26268133 |
| 59 | negative regulation of growth of symbiont in host (GO:0044130) | 3.26268133 |
| 60 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.26268133 |
| 61 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.26268133 |
| 62 | regulation of mast cell degranulation (GO:0043304) | 3.25014462 |
| 63 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.24499949 |
| 64 | killing of cells of other organism (GO:0031640) | 3.23822471 |
| 65 | disruption of cells of other organism (GO:0044364) | 3.23822471 |
| 66 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.23808063 |
| 67 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.23630617 |
| 68 | negative regulation of T cell mediated immunity (GO:0002710) | 3.20412086 |
| 69 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.17623606 |
| 70 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.17157090 |
| 71 | immunoglobulin mediated immune response (GO:0016064) | 3.15433846 |
| 72 | superoxide anion generation (GO:0042554) | 3.12264197 |
| 73 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.11633635 |
| 74 | activated T cell proliferation (GO:0050798) | 3.10720649 |
| 75 | interferon-gamma production (GO:0032609) | 3.08474688 |
| 76 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.07543484 |
| 77 | granulocyte chemotaxis (GO:0071621) | 3.01286824 |
| 78 | defense response to protozoan (GO:0042832) | 3.00635592 |
| 79 | leukocyte degranulation (GO:0043299) | 2.99529618 |
| 80 | mast cell activation (GO:0045576) | 2.97421385 |
| 81 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.95898305 |
| 82 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.94401336 |
| 83 | granulocyte migration (GO:0097530) | 2.93538346 |
| 84 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.91039310 |
| 85 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.89648294 |
| 86 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.87564396 |
| 87 | reactive oxygen species biosynthetic process (GO:1903409) | 2.85987399 |
| 88 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.84308504 |
| 89 | response to protozoan (GO:0001562) | 2.83356399 |
| 90 | cytokine secretion (GO:0050663) | 2.81102895 |
| 91 | response to muramyl dipeptide (GO:0032495) | 2.80954289 |
| 92 | fucose catabolic process (GO:0019317) | 2.80841785 |
| 93 | L-fucose metabolic process (GO:0042354) | 2.80841785 |
| 94 | L-fucose catabolic process (GO:0042355) | 2.80841785 |
| 95 | myeloid leukocyte activation (GO:0002274) | 2.78419215 |
| 96 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.78282619 |
| 97 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.73807211 |
| 98 | negative regulation of interleukin-8 production (GO:0032717) | 2.72178703 |
| 99 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.71430949 |
| 100 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.69095591 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.63804106 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.47309236 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.99366572 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.51349574 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.88259531 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.72956224 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54941033 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.51556350 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.34574183 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.33369241 |
| 11 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.24208712 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.21781269 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.15206763 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.04335898 |
| 15 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04245337 |
| 16 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.97311024 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.93866322 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83198268 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.79193627 |
| 20 | GATA3_26560356_Chip-Seq_TH2_Human | 1.78164003 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77102247 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71921010 |
| 23 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.71767195 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 1.68328468 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 1.66672840 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.64379415 |
| 27 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.63450496 |
| 28 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.60042262 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57221691 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.53535376 |
| 31 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.51538289 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.49759560 |
| 33 | VDR_22108803_ChIP-Seq_LS180_Human | 1.48359073 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.47903939 |
| 35 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46996482 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46179555 |
| 37 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.45322798 |
| 38 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.38192363 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37695462 |
| 40 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.37659396 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36168140 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.36140941 |
| 43 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35179021 |
| 44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29917581 |
| 45 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23875014 |
| 46 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.21619272 |
| 47 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20892239 |
| 48 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.17421878 |
| 49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.17339614 |
| 50 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14990203 |
| 51 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.13950345 |
| 52 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13806709 |
| 53 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13229742 |
| 54 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12876303 |
| 55 | MYB_26560356_Chip-Seq_TH1_Human | 1.12446841 |
| 56 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.10756996 |
| 57 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10582409 |
| 58 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.09627277 |
| 59 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09584478 |
| 60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08003964 |
| 61 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06793817 |
| 62 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.05539377 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.03358900 |
| 64 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.02193968 |
| 65 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.01924428 |
| 66 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.01366100 |
| 67 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.00767406 |
| 68 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00764989 |
| 69 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00710291 |
| 70 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00710291 |
| 71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.00289141 |
| 72 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.99742206 |
| 73 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98902970 |
| 74 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97141248 |
| 75 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96745681 |
| 76 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.95557112 |
| 77 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.93956378 |
| 78 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.92786265 |
| 79 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.91682528 |
| 80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.89850182 |
| 81 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89703895 |
| 82 | MAF_26560356_Chip-Seq_TH1_Human | 0.89624481 |
| 83 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.89225397 |
| 84 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.88902009 |
| 85 | P300_19829295_ChIP-Seq_ESCs_Human | 0.88769331 |
| 86 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.88484946 |
| 87 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.88470095 |
| 88 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87911229 |
| 89 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87714602 |
| 90 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.87379267 |
| 91 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.87379267 |
| 92 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.86535530 |
| 93 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.85198675 |
| 94 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.85103054 |
| 95 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84868257 |
| 96 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83548642 |
| 97 | GATA3_26560356_Chip-Seq_TH1_Human | 0.83325390 |
| 98 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82879791 |
| 99 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.82463228 |
| 100 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.82463228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.81643631 |
| 2 | MP0003303_peritoneal_inflammation | 3.78214729 |
| 3 | MP0003436_decreased_susceptibility_to | 3.62804520 |
| 4 | MP0009785_altered_susceptibility_to | 3.26111469 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.11922082 |
| 6 | MP0002419_abnormal_innate_immunity | 3.10877292 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.89012514 |
| 8 | MP0005671_abnormal_response_to | 2.72543597 |
| 9 | MP0005025_abnormal_response_to | 2.64178074 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.62903363 |
| 11 | MP0001800_abnormal_humoral_immune | 2.55789794 |
| 12 | MP0009764_decreased_sensitivity_to | 2.55638666 |
| 13 | MP0006082_CNS_inflammation | 2.46591155 |
| 14 | MP0000685_abnormal_immune_system | 2.42900219 |
| 15 | MP0005387_immune_system_phenotype | 2.42510991 |
| 16 | MP0001790_abnormal_immune_system | 2.42510991 |
| 17 | MP0002723_abnormal_immune_serum | 2.39094381 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.36933371 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.22606140 |
| 20 | MP0001819_abnormal_immune_cell | 2.20073726 |
| 21 | MP0009278_abnormal_bone_marrow | 2.17538564 |
| 22 | MP0003195_calcinosis | 2.08992777 |
| 23 | MP0000569_abnormal_digit_pigmentation | 2.06742620 |
| 24 | MP0001533_abnormal_skeleton_physiology | 1.98936743 |
| 25 | MP0002277_abnormal_respiratory_mucosa | 1.89050919 |
| 26 | MP0005167_abnormal_blood-brain_barrier | 1.80415830 |
| 27 | MP0001845_abnormal_inflammatory_respons | 1.78825487 |
| 28 | MP0002405_respiratory_system_inflammati | 1.76716808 |
| 29 | MP0003828_pulmonary_edema | 1.60305539 |
| 30 | MP0000716_abnormal_immune_system | 1.53632593 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.51420197 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.48503805 |
| 33 | MP0008469_abnormal_protein_level | 1.45349302 |
| 34 | MP0003075_altered_response_to | 1.42307341 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.41189454 |
| 36 | MP0005310_abnormal_salivary_gland | 1.37731075 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.37215983 |
| 38 | MP0001986_abnormal_taste_sensitivity | 1.34062603 |
| 39 | MP0002398_abnormal_bone_marrow | 1.33556731 |
| 40 | MP0004947_skin_inflammation | 1.32297956 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.31230322 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.31230322 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.22480536 |
| 44 | MP0004510_myositis | 1.19841893 |
| 45 | MP0003646_muscle_fatigue | 1.18786675 |
| 46 | MP0000343_altered_response_to | 1.18713506 |
| 47 | MP0002132_abnormal_respiratory_system | 1.17888922 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.13896228 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 1.13356674 |
| 50 | MP0002429_abnormal_blood_cell | 1.10990731 |
| 51 | MP0002722_abnormal_immune_system | 1.09874707 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.08294765 |
| 53 | MP0005164_abnormal_response_to | 1.07514026 |
| 54 | MP0001501_abnormal_sleep_pattern | 1.03046694 |
| 55 | MP0001663_abnormal_digestive_system | 1.02330872 |
| 56 | MP0008004_abnormal_stomach_pH | 1.00812915 |
| 57 | MP0008875_abnormal_xenobiotic_pharmacok | 0.99872170 |
| 58 | MP0009765_abnormal_xenobiotic_induced | 0.98056854 |
| 59 | MP0004883_abnormal_blood_vessel | 0.97400892 |
| 60 | MP0005166_decreased_susceptibility_to | 0.94349959 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 0.92296299 |
| 62 | MP0002998_abnormal_bone_remodeling | 0.91110994 |
| 63 | MP0005174_abnormal_tail_pigmentation | 0.90746801 |
| 64 | MP0001853_heart_inflammation | 0.88963526 |
| 65 | MP0003866_abnormal_defecation | 0.88475963 |
| 66 | MP0003763_abnormal_thymus_physiology | 0.87612895 |
| 67 | MP0002653_abnormal_ependyma_morphology | 0.87610142 |
| 68 | MP0008877_abnormal_DNA_methylation | 0.87458629 |
| 69 | MP0003806_abnormal_nucleotide_metabolis | 0.87147776 |
| 70 | MP0000015_abnormal_ear_pigmentation | 0.85480582 |
| 71 | MP0005083_abnormal_biliary_tract | 0.84594101 |
| 72 | MP0002332_abnormal_exercise_endurance | 0.84542876 |
| 73 | MP0002254_reproductive_system_inflammat | 0.82642810 |
| 74 | MP0001873_stomach_inflammation | 0.82605140 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 0.82354354 |
| 76 | MP0002006_tumorigenesis | 0.81995739 |
| 77 | MP0004142_abnormal_muscle_tone | 0.81887897 |
| 78 | MP0002693_abnormal_pancreas_physiology | 0.80812501 |
| 79 | MP0009763_increased_sensitivity_to | 0.80663140 |
| 80 | MP0004484_altered_response_of | 0.80206013 |
| 81 | MP0003252_abnormal_bile_duct | 0.79009167 |
| 82 | MP0003045_fibrosis | 0.78300156 |
| 83 | MP0003690_abnormal_glial_cell | 0.77368566 |
| 84 | MP0004043_abnormal_pH_regulation | 0.76186024 |
| 85 | MP0005390_skeleton_phenotype | 0.74030788 |
| 86 | MP0008872_abnormal_physiological_respon | 0.73802103 |
| 87 | MP0001851_eye_inflammation | 0.73722256 |
| 88 | MP0008961_abnormal_basal_metabolism | 0.73608404 |
| 89 | MP0003191_abnormal_cellular_cholesterol | 0.71597383 |
| 90 | MP0004381_abnormal_hair_follicle | 0.70949797 |
| 91 | MP0000703_abnormal_thymus_morphology | 0.70733849 |
| 92 | MP0005084_abnormal_gallbladder_morpholo | 0.69840500 |
| 93 | MP0003787_abnormal_imprinting | 0.68324330 |
| 94 | MP0003011_delayed_dark_adaptation | 0.68266532 |
| 95 | MP0005535_abnormal_body_temperature | 0.66279695 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.65906550 |
| 97 | MP0004742_abnormal_vestibular_system | 0.65652691 |
| 98 | MP0004130_abnormal_muscle_cell | 0.64865844 |
| 99 | MP0000604_amyloidosis | 0.63712480 |
| 100 | MP0003448_altered_tumor_morphology | 0.62578520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 6.20848389 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 5.57679299 |
| 3 | Optic neuritis (HP:0100653) | 5.57679299 |
| 4 | Myositis (HP:0100614) | 5.43906974 |
| 5 | Orchitis (HP:0100796) | 5.33361198 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.96795316 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.95446893 |
| 8 | Recurrent abscess formation (HP:0002722) | 4.73870783 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.50898222 |
| 10 | Eczematoid dermatitis (HP:0000976) | 4.49442058 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.91202733 |
| 12 | Keratoconjunctivitis sicca (HP:0001097) | 3.79281128 |
| 13 | Keratoconjunctivitis (HP:0001096) | 3.77887205 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.72730058 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.51017295 |
| 16 | Encephalitis (HP:0002383) | 3.45516637 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 3.42300546 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.38358840 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.38358840 |
| 20 | Episodic fever (HP:0001954) | 3.36112347 |
| 21 | Recurrent skin infections (HP:0001581) | 3.36079054 |
| 22 | Hemoptysis (HP:0002105) | 3.26860967 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.12175377 |
| 24 | Obstructive lung disease (HP:0006536) | 3.12175377 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 3.11366069 |
| 26 | Vasculitis (HP:0002633) | 3.06968181 |
| 27 | Pulmonary infiltrates (HP:0002113) | 2.97117235 |
| 28 | Meningitis (HP:0001287) | 2.96403042 |
| 29 | Increased cerebral lipofuscin (HP:0011813) | 2.85576171 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.84819180 |
| 31 | Leukocytosis (HP:0001974) | 2.84072579 |
| 32 | Urticaria (HP:0001025) | 2.79846734 |
| 33 | Gangrene (HP:0100758) | 2.79761563 |
| 34 | Congenital stationary night blindness (HP:0007642) | 2.73690029 |
| 35 | Anorexia (HP:0002039) | 2.71473987 |
| 36 | Amyloidosis (HP:0011034) | 2.70122164 |
| 37 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.53918285 |
| 38 | Arterial thrombosis (HP:0004420) | 2.47867047 |
| 39 | Pancreatic cysts (HP:0001737) | 2.45051154 |
| 40 | Abnormality of the pleura (HP:0002103) | 2.35972047 |
| 41 | Stomach cancer (HP:0012126) | 2.35628450 |
| 42 | Abolished electroretinogram (ERG) (HP:0000550) | 2.34990884 |
| 43 | Autoimmune thrombocytopenia (HP:0001973) | 2.33521961 |
| 44 | Chest pain (HP:0100749) | 2.32612436 |
| 45 | Attenuation of retinal blood vessels (HP:0007843) | 2.31271018 |
| 46 | Abnormality of T cell number (HP:0011839) | 2.30415470 |
| 47 | Hematochezia (HP:0002573) | 2.25406596 |
| 48 | Pulmonary embolism (HP:0002204) | 2.24238962 |
| 49 | Polyneuropathy (HP:0001271) | 2.23317582 |
| 50 | Prolonged bleeding time (HP:0003010) | 2.21507048 |
| 51 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.21443193 |
| 52 | Hypochromic microcytic anemia (HP:0004840) | 2.18024507 |
| 53 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.16293374 |
| 54 | Vacuolated lymphocytes (HP:0001922) | 2.16112034 |
| 55 | Abnormality of glycolipid metabolism (HP:0010969) | 2.15865101 |
| 56 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.15865101 |
| 57 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.15865101 |
| 58 | Hypochromic anemia (HP:0001931) | 2.15690799 |
| 59 | T lymphocytopenia (HP:0005403) | 2.14822728 |
| 60 | Pustule (HP:0200039) | 2.14639681 |
| 61 | Abnormality of T cells (HP:0002843) | 2.14217720 |
| 62 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.10374904 |
| 63 | Gingivitis (HP:0000230) | 2.07602411 |
| 64 | Abnormality of T cell physiology (HP:0011840) | 2.07183302 |
| 65 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.05139090 |
| 66 | Decreased central vision (HP:0007663) | 2.04006744 |
| 67 | Vertigo (HP:0002321) | 2.02711981 |
| 68 | Abnormality of midbrain morphology (HP:0002418) | 2.01783607 |
| 69 | Molar tooth sign on MRI (HP:0002419) | 2.01783607 |
| 70 | Keratitis (HP:0000491) | 2.01553417 |
| 71 | Constricted visual fields (HP:0001133) | 2.00392303 |
| 72 | Eosinophilia (HP:0001880) | 1.99865078 |
| 73 | Increased serum ferritin (HP:0003281) | 1.98345742 |
| 74 | Abnormality of eosinophils (HP:0001879) | 1.98099836 |
| 75 | Progressive inability to walk (HP:0002505) | 1.94702288 |
| 76 | True hermaphroditism (HP:0010459) | 1.93819519 |
| 77 | Abnormality of iron homeostasis (HP:0011031) | 1.93608212 |
| 78 | Pancreatic fibrosis (HP:0100732) | 1.93013186 |
| 79 | Clumsiness (HP:0002312) | 1.91145930 |
| 80 | Increased IgE level (HP:0003212) | 1.89577718 |
| 81 | Spontaneous hematomas (HP:0007420) | 1.89561825 |
| 82 | Abnormality of the endocardium (HP:0004306) | 1.88012910 |
| 83 | Panhypogammaglobulinemia (HP:0003139) | 1.86890598 |
| 84 | Recurrent viral infections (HP:0004429) | 1.86723591 |
| 85 | Cheilitis (HP:0100825) | 1.84711419 |
| 86 | Agitation (HP:0000713) | 1.84238625 |
| 87 | Abnormality of the pericardium (HP:0001697) | 1.81354562 |
| 88 | Hyperventilation (HP:0002883) | 1.81351958 |
| 89 | Granulocytopenia (HP:0001913) | 1.80458727 |
| 90 | Gingival bleeding (HP:0000225) | 1.75491248 |
| 91 | Genetic anticipation (HP:0003743) | 1.75442808 |
| 92 | Epistaxis (HP:0000421) | 1.74272636 |
| 93 | Acne (HP:0001061) | 1.72130076 |
| 94 | Inability to walk (HP:0002540) | 1.72110202 |
| 95 | Absent/shortened dynein arms (HP:0200106) | 1.72043456 |
| 96 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.72043456 |
| 97 | Abnormality of B cell number (HP:0010975) | 1.70903921 |
| 98 | Petechiae (HP:0000967) | 1.70762248 |
| 99 | Increased IgM level (HP:0003496) | 1.70092061 |
| 100 | Progressive cerebellar ataxia (HP:0002073) | 1.68200002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.44777540 |
| 2 | BLK | 3.24344374 |
| 3 | TXK | 3.16111362 |
| 4 | IRAK4 | 3.02028856 |
| 5 | FRK | 2.93653443 |
| 6 | TAOK3 | 2.59907882 |
| 7 | MAP4K1 | 2.51719562 |
| 8 | ADRBK2 | 2.30909851 |
| 9 | IRAK3 | 2.29511921 |
| 10 | CSK | 2.17023609 |
| 11 | IRAK1 | 2.11530615 |
| 12 | ACVR1B | 1.93897386 |
| 13 | FES | 1.93358583 |
| 14 | MAP2K3 | 1.88062989 |
| 15 | IKBKE | 1.85832115 |
| 16 | ZAP70 | 1.79694317 |
| 17 | GRK6 | 1.74088741 |
| 18 | SYK | 1.71779922 |
| 19 | TYK2 | 1.70840600 |
| 20 | MAP3K14 | 1.69476430 |
| 21 | IKBKB | 1.67703138 |
| 22 | CAMKK2 | 1.66628979 |
| 23 | DAPK2 | 1.66466004 |
| 24 | KIT | 1.58326289 |
| 25 | MATK | 1.56744948 |
| 26 | TNK2 | 1.51724141 |
| 27 | FGR | 1.47684269 |
| 28 | BMPR1B | 1.41239050 |
| 29 | LYN | 1.34699269 |
| 30 | BMPR2 | 1.32185032 |
| 31 | HCK | 1.25593588 |
| 32 | BTK | 1.23898766 |
| 33 | JAK3 | 1.23824013 |
| 34 | CAMK1D | 1.23549422 |
| 35 | IRAK2 | 1.17979188 |
| 36 | TEC | 1.17731061 |
| 37 | TAOK1 | 1.13044708 |
| 38 | TBK1 | 1.12495022 |
| 39 | MAP3K11 | 1.09586110 |
| 40 | JAK2 | 1.07868481 |
| 41 | GRK1 | 1.07658684 |
| 42 | CHUK | 1.06727540 |
| 43 | PIK3CG | 1.05055477 |
| 44 | GRK7 | 1.01696354 |
| 45 | ITK | 0.97054557 |
| 46 | LCK | 0.95686572 |
| 47 | MARK3 | 0.94417993 |
| 48 | INSRR | 0.89234211 |
| 49 | MAP2K6 | 0.88283752 |
| 50 | MAP3K3 | 0.87778736 |
| 51 | EPHB1 | 0.86164684 |
| 52 | WNK3 | 0.84304487 |
| 53 | MAP4K2 | 0.81568343 |
| 54 | TLK1 | 0.81045243 |
| 55 | PINK1 | 0.81000280 |
| 56 | SIK2 | 0.78755648 |
| 57 | PTK2B | 0.77921459 |
| 58 | JAK1 | 0.77879631 |
| 59 | CSF1R | 0.77643926 |
| 60 | OXSR1 | 0.77249380 |
| 61 | SIK3 | 0.76336162 |
| 62 | EPHA3 | 0.75388104 |
| 63 | ADRBK1 | 0.74917966 |
| 64 | WNK4 | 0.72866204 |
| 65 | NUAK1 | 0.71325833 |
| 66 | MAP3K1 | 0.70428014 |
| 67 | ERN1 | 0.70382759 |
| 68 | STK11 | 0.68141747 |
| 69 | MAPK13 | 0.65005245 |
| 70 | MAP2K4 | 0.62268648 |
| 71 | CAMK1G | 0.60423774 |
| 72 | PRKCQ | 0.57908231 |
| 73 | MAP3K2 | 0.56631481 |
| 74 | WNK1 | 0.54809743 |
| 75 | PDK1 | 0.53102133 |
| 76 | YES1 | 0.53053069 |
| 77 | ZAK | 0.52273158 |
| 78 | TGFBR2 | 0.51228384 |
| 79 | PAK3 | 0.49302722 |
| 80 | KSR2 | 0.47633380 |
| 81 | RPS6KA6 | 0.46910935 |
| 82 | CAMK4 | 0.45593774 |
| 83 | PIM1 | 0.44864979 |
| 84 | CAMK1 | 0.43488481 |
| 85 | MAP3K7 | 0.43362908 |
| 86 | PRKAA2 | 0.42358720 |
| 87 | MAP3K5 | 0.42294029 |
| 88 | PIK3CA | 0.41500000 |
| 89 | SGK2 | 0.39678054 |
| 90 | PRKD2 | 0.38371603 |
| 91 | MARK2 | 0.38217434 |
| 92 | ABL1 | 0.38180023 |
| 93 | MAPK12 | 0.37859915 |
| 94 | MAPK7 | 0.37657065 |
| 95 | STK24 | 0.37497655 |
| 96 | TRPM7 | 0.35612067 |
| 97 | FYN | 0.34578362 |
| 98 | TGFBR1 | 0.34437772 |
| 99 | PRKCZ | 0.33615013 |
| 100 | HIPK2 | 0.32789620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.96182134 |
| 2 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.89366476 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.77930601 |
| 4 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.50207627 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.43219885 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.41766490 |
| 7 | Tuberculosis_Homo sapiens_hsa05152 | 2.27835497 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.24864921 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.09028367 |
| 10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.02545813 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.98736310 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.97770433 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.95541739 |
| 14 | Malaria_Homo sapiens_hsa05144 | 1.92219826 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.91182870 |
| 16 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.86677929 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.86035742 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.74569888 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.70736090 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.67699354 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.60765542 |
| 22 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.53059972 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.50091856 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.47957803 |
| 25 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.47043057 |
| 26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.45331929 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.42139219 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.37389783 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35774434 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.33282253 |
| 31 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.32075901 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30957759 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30146211 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29831286 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.26253255 |
| 36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.18702655 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.18597543 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.17493421 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.16442428 |
| 40 | * Phagosome_Homo sapiens_hsa04145 | 1.12391170 |
| 41 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.11681218 |
| 42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.10910538 |
| 43 | Lysosome_Homo sapiens_hsa04142 | 1.06583292 |
| 44 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.06359272 |
| 45 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.06100698 |
| 46 | Phototransduction_Homo sapiens_hsa04744 | 1.04480932 |
| 47 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.04219117 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.03670231 |
| 49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.02021484 |
| 50 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.01537045 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00787077 |
| 52 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.96673162 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.96125030 |
| 54 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.91444768 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87711314 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.85655392 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.81412834 |
| 58 | Platelet activation_Homo sapiens_hsa04611 | 0.80126237 |
| 59 | Hepatitis B_Homo sapiens_hsa05161 | 0.73559393 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.73422865 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72626528 |
| 62 | Morphine addiction_Homo sapiens_hsa05032 | 0.71537591 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71107647 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69451282 |
| 65 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68484763 |
| 66 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.67428837 |
| 67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62218264 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57999799 |
| 69 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57767894 |
| 70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57257608 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.55899744 |
| 72 | Olfactory transduction_Homo sapiens_hsa04740 | 0.55694656 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53096788 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52400236 |
| 75 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.51359495 |
| 76 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50693022 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49258078 |
| 78 | Mineral absorption_Homo sapiens_hsa04978 | 0.47974812 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47811353 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46944396 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46735460 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45969008 |
| 83 | Shigellosis_Homo sapiens_hsa05131 | 0.45486092 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44672150 |
| 85 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.44629026 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.44229020 |
| 87 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.40547294 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.40266283 |
| 89 | Apoptosis_Homo sapiens_hsa04210 | 0.38786433 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38136781 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.36020548 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31602987 |
| 93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31033725 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31009513 |
| 95 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.29593607 |
| 96 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.29584723 |
| 97 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.29407999 |
| 98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.28783721 |
| 99 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.27100602 |
| 100 | Long-term depression_Homo sapiens_hsa04730 | 0.25754878 |

